192 related articles for article (PubMed ID: 12488144)
21. High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer.
Hirche C; Mohr Z; Kneif S; Murawa D; Hünerbein M
J Surg Oncol; 2012 Feb; 105(2):162-6. PubMed ID: 21882198
[TBL] [Abstract][Full Text] [Related]
22. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases.
Boler DE; Uras C; Ince U; Cabioglu N
Breast; 2012 Aug; 21(4):518-23. PubMed ID: 22410110
[TBL] [Abstract][Full Text] [Related]
23. Triple assessment of sentinel lymph node metastasis in early breast cancer using preoperative CTLG, intraoperative fluorescence navigation and OSNA.
Mokhtar M; Tadokoro Y; Nakagawa M; Morimoto M; Takechi H; Kondo K; Tangoku A
Breast Cancer; 2016 Mar; 23(2):202-10. PubMed ID: 25069434
[TBL] [Abstract][Full Text] [Related]
24. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS).
Reyna C; Kiluk JV; Frelick A; Khakpour N; Laronga C; Lee MC
J Surg Oncol; 2015 Jun; 111(7):813-8. PubMed ID: 25753101
[TBL] [Abstract][Full Text] [Related]
25. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
[TBL] [Abstract][Full Text] [Related]
26. Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.
Adachi Y; Sawaki M; Hattori M; Yoshimura A; Gondo N; Kotani H; Iwase M; Kataoka A; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Oze I; Iwata H
Breast Cancer; 2018 Sep; 25(5):560-565. PubMed ID: 29536376
[TBL] [Abstract][Full Text] [Related]
27. Risk factor for axillary lymph node metastases in microinvasive breast cancer.
Ko BS; Lim WS; Kim HJ; Yu JH; Lee JW; Kwan SB; Lee YM; Son BH; Gong GY; Ahn SH
Ann Surg Oncol; 2012 Jan; 19(1):212-6. PubMed ID: 21633867
[TBL] [Abstract][Full Text] [Related]
28. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
[TBL] [Abstract][Full Text] [Related]
29. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V
Tumori; 2015; 101(3):298-305. PubMed ID: 25838248
[TBL] [Abstract][Full Text] [Related]
30. The safety and accuracy of sentinel-node biopsy in early-stage invasive breast cancer--Turkish experience.
Kebudi A; Işgör A; Atay M; Yetkin G; Yazici D; Yildiz A
J Invest Surg; 2005; 18(3):129-34. PubMed ID: 16036784
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
Gherghe M; Bordea C; Blidaru A
Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
[TBL] [Abstract][Full Text] [Related]
32. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
33. Accurate staging with internal mammary chain sentinel node biopsy for breast cancer.
Gnerlich JL; Barreto-Andrade JC; Czechura T; John JR; Turk MA; Kennedy TJ; Winchester DJ
Ann Surg Oncol; 2014 Feb; 21(2):368-74. PubMed ID: 24046119
[TBL] [Abstract][Full Text] [Related]
34. Detailed evaluation of one step nucleic acid (OSNA) molecular assay for intra-operative diagnosis of sentinel lymph node metastasis and prediction of non-sentinel nodal involvement: experience from a London teaching hospital.
Banerjee SM; Michalopoulos NV; Williams NR; Davidson T; El Sheikh S; McDermott N; Tran-Dang MA; Davison S; Keshtgar MR
Breast; 2014 Aug; 23(4):378-84. PubMed ID: 24630617
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous Sentinel Node Biopsy in Breast Cancer: Results of a Phase 1 Study.
Pairawan SS; Cora C; Olaya W; Deisch J; Garberoglio R; Solomon N; Senthil M; Garberoglio C; Lum SS
Ann Surg Oncol; 2016 Oct; 23(10):3330-6. PubMed ID: 27334213
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node pressure in breast cancer.
Nathanson SD; Mahan M
Ann Surg Oncol; 2011 Dec; 18(13):3791-6. PubMed ID: 21626079
[TBL] [Abstract][Full Text] [Related]
37. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.
Albertini JJ; Lyman GH; Cox C; Yeatman T; Balducci L; Ku N; Shivers S; Berman C; Wells K; Rapaport D; Shons A; Horton J; Greenberg H; Nicosia S; Clark R; Cantor A; Reintgen DS
JAMA; 1996 Dec; 276(22):1818-22. PubMed ID: 8946902
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
[TBL] [Abstract][Full Text] [Related]
39. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
40. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.
Langer I; Marti WR; Guller U; Moch H; Harder F; Oertli D; Zuber M
Ann Surg; 2005 Jan; 241(1):152-8. PubMed ID: 15622003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
